drugset / Trial / NCT04877587
Gemcitabine With Ascorbate Including Adolescents
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this research study is to see if a high dose of ascorbate (Vitamin C), in combination with the chemotherapy drug gemcitabine, is safe and effective in adolescents with locally advanced unresectable or metastatic soft tissue and bone sarcomas
Timeline
- Start
- 2023-01
- Primary completion
- 2025-05-31
- Completion
- 2025-05-31
Outcome
Outcome not reported
Stopped (Enrollment): “Unable to enroll”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ascorbate | Unknown | 60 g | Intravenous |
| Background | Gemcitabine | Small molecule | 900 mg/m2 | — |